Read Our News

Filter by:

Register Now for FWGBD’s Uterine Hemostasis Colloquium II

Uterine Hemostasis Colloquium II Preceding the HTRS/NASTH 2019 Scientific Symposium https://www.htrs.org/HTRS/Education-Events/HTRSNASTH-2019-Scientific-Sympoisum Program Co-Chairs:  Andra H. James, MD, MPH, and Kenneth G. Mann, PhD Program Description:…

RFI from NHLBI: To Improve Treatment of Patients with the Severe Hemophilia A Phenotype

Soliciting Input for future research at the National Heart, Lung, and Blood Institute on Factor VIII (FVIII) immunogenicity and FVIII inhibitor prevention/eradication in patients with…

Improved Quality of Life for Adolescents with Heavy Menstrual Bleeding

What exactly is “quality of life”? To match objective measurements of menstrual bleeding and pair them with a rather subjective quality of life ideal, Tazim…

Grant Recipient Uses Mobile Device Observation in Sickle Cell Pain Study

Technology takes center stage in a new epidemiologic study of acute vaso-occlusive pain associated with menstruation in women with sickle cell disease (SCD). Deva Sharma,…

Our Grant Funds a Mission, at Once Global and Personal

When she began her medical training in India at Maulana Azad Medical College, Ruchika Sharma, MD noticed an alarming reality: “I saw a population of…

Collaboration Is Queen: Our Grant Fosters Interdisciplinary Medicine

Speaking with Julia Coleman, MD on the phone, you immediately get a vivid sense of her enthusiasm, one that doesn’t come through in email –…

Grant Opportunity: 2019 HTRS Mentored Research Award Program

The Hemostasis and Thrombosis Research Society’s Mentored Research Award Program (HTRS MRA) provides financial support for qualified fellows or junior attending/junior faculty pursuing clinical, translational, or basic…

NHLBI Announces Two New Funding Opportunities

The National Heart, Lung, and Blood Institute (NHLBI) has recently released two new Funding Opportunity Announcements (FOAs): Catalyzing Innovation in Late Phase Clinical Trial Design. The purpose…

New Directory for Women & Girls with Sickle Cell Disease

FWGBD is pleased to announce a new service map directory that shares information about the availability and range of services specifically devoted to the care…

Announcing the 2018 Promoting XXcellence in Women’s Health: Optimal Management of Women and Girls with Blood Disorders and Bleeding Disorders Award Winners

The Foundation for Women & Girls with Blood Disorders is pleased to announce the two winners of 2018 Promoting XXcellence in Women’s Health: Optimal Management of…

In Memory of Dr. Joan Cox Gill (6/23/43-5/9/18) A Force for Good in the Lives of So Many People

It is with great sadness that FWGBD shares the passing of Dr. Joan Cox Gill, a friend to the foundation and valued member of our…

FDA Approves Hydroxyurea Tablets for Pediatric Sickle Cell Anemia

On December 21, 2017, the U.S. Food and Drug Administration approved the use of hydroxyurea tablets in pediatric patients with sickle cell anemia to reduce…

An Interview with Dr. Andra James, MD, MPH

Recently ASH Clinical News interviewed Dr. Andra James, President of FWGBD's Board of Directors, about her career path. Click on the link below to hear…

NHLBI State-of-Science Workshop

This event has ended. For meeting updates, please revisit the website and follow NHLBI on Twitter: https://twitter.com/NHLBI_BLOODDir Factor VIII Inhibitors: Generating a National Blueprint for Future Research WHEN: May…

Save The Date: Advancing Hemophilia Care Through Genomics Webinar

Topic: My Life, My Future: Advancing Hemophilia Care Through Genomics Guest Presenter: Barbara A. Konkle, MD Date: February 22, 2018, at 2-3 PM ET Learning…